Andrew Berg

Andrew Berg is an experienced investor currently working at Companyon Ventures, where the focus is on investing in early-stage B2B software startups poised for significant growth. Berg also serves as an Investment Analyst at Chargeblast and as a Board Observer for POSH, while previously holding the position of Board Observer and Investor at Cannon Project. A substantial role as a Business Analyst at Cannon Ventures involved extensive diligence on emerging series A startups and talent identification within tech. Earlier experiences include a Business Development Intern role at HALE Sports and a similar position at Tru, Inc., as well as research assistance at Beth Israel Deaconess Medical Center under Dr. Cliff Saper. Andrew Berg holds a Bachelor of Arts in Neuroscience and Entrepreneurship from Princeton University and graduated Magna Cum Laude from Belmont Hill School.